PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery
Despite major advances in the understanding of the pathogenesis of idiopathic pulmonary fibrosis (IPF), diagnosis and management of the condition continue to pose significant challenges. Clinical management of IPF remains unsatisfactory due to limited availability of effective drug therapies, a lack...
Main Author: | Toby M. Maher |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2013-06-01
|
Series: | European Respiratory Review |
Subjects: | |
Online Access: | http://err.ersjournals.com/content/22/128/148.full.pdf+html |
Similar Items
-
Molecular Biomarkers in Idiopathic Pulmonary Fibrosis: State of the Art and Future Directions
by: Anna Stainer, et al.
Published: (2021-06-01) -
Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis.
by: Sokai, Akihiko
Published: (2016) -
Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics
by: Feng Yan, et al.
Published: (2017-12-01) -
Prognostic impact of the ratio of the main pulmonary artery to that of the aorta on chest computed tomography in patients with idiopathic pulmonary fibrosis
by: Ji Soo Choi, et al.
Published: (2019-04-01) -
The Management of Patients With Idiopathic Pulmonary Fibrosis
by: Paolo Spagnolo, et al.
Published: (2018-07-01)